Description
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone. It has been characterized in preclinical research as a non-selective melanocortin receptor agonist, making it a useful tool compound for isolating melanocortin pathway endpoints in experimental designs.
PT-141 has been used in preclinical in vitro and rodent model studies to investigate melanocortin receptor signaling, central nervous system-mediated behavioral paradigms, neuroendocrine response characterization, and downstream second-messenger activity. Its defined receptor profile supports mechanistic studies of the melanocortin system in laboratory research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.